A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Intensity Therapeutics, Inc.
Alliance for Clinical Trials in Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
VA Office of Research and Development
Pfizer
Pfizer
Massachusetts General Hospital
Pfizer
Hackensack Meridian Health
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Stanford University
Masonic Cancer Center, University of Minnesota
University of Kansas Medical Center
Roswell Park Cancer Institute
Fox Chase Cancer Center
Curis, Inc.
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital